Floatz logo

Acetylsalicylic Acid

Ischemic Heart Disease

Rajaie Cardiovascular Medical and Research CenterPhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Ischemic Heart Disease cohort.

Asset / SponsorPhaseRating
Ranolazine
East Carolina University
Phase 4A
ATENOLOL
Xintong Pharmacy Company
Phase 4BBB
Ranolazine
East Carolina University
Phase 4BBB
Nebido
Sheffield Teaching Hospitals NHS Foundation Trust
Phase 4BB
3-(2,2,2-TRIMETHYLDIAZANIUMYL)PROPANOATE
Burnasyan Federal Medical Biophysical Center
Phase 4BB

View all 35 →

Same molecule, other indications

Acetylsalicylic Acid is also rated in:

myocardial infarctionDormant
A
Indicative ·
83 / 100
View asset →
coronary artery disorderDormant
BBB
Indicative ·
79 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →